Vaniqa is a topical cream that is used to reduce the growth of facial hair in women. Its active ingredient eflornithine works by inhibiting the enzyme ornithine decarboxylase which is involved in cell proliferation. By blocking this enzyme the cream slows the division of hair follicle cells and extends the resting phase of the hair cycle. The reduction in cell activity leads to finer and slower growing hair on the treated areas of the face. This medication provides a long-term decrease in visible hair density. This mechanism helps improve appearance for individuals seeking to manage excessive facial hair without systemic medications.

Vaniqa is a prescription topical medication used to reduce unwanted facial hair in women. Its active ingredient, eflornithine, functions as an irreversible inhibitor of the enzyme ornithine decarboxylase. This enzyme catalyzes a step in the synthesis of polyamines that are required for cell growth and hair follicle activity. By blocking polyamine production, eflornithine slows the proliferation of hair cells and delays the emergence of new hairs. The cream is applied to the skin where it penetrates locally and exerts its effect without systemic absorption. The overall pharmacological profile of Vaniqa involves topical delivery, enzyme inhibition, and gradual reduction of unwanted facial hair growth.

Vaniqa may cause skin irritation at the application site and some users experience dryness or itching. Headache dizziness and abdominal discomfort have also been reported occasionally. Changes in taste such as a metallic sensation have been noted in rare cases. Mild rash or redness can appear usually transient and not severe. In very rare instances allergic reactions like swelling or hives may develop. These symptoms typically resolve after discontinuation but persistent or worsening signs should be monitored. Overall the medication is generally well tolerated yet awareness of possible side effects helps users make informed choices.

Vaniqa is a prescription cream used for facial hair reduction. Common side effects include mild skin irritation at the application site. Some users may experience tingling or burning sensations that usually fade quickly. Rarely, changes in skin color or texture can occur. Headache and abdominal discomfort have been reported in a small number of cases. Most side effects are temporary and resolve without medical intervention. If any reaction persists or worsens, a healthcare professional should be consulted.